General Statement of Disclosure:

CONSULTING FEES/HONORARIA: Boehringer Ingelheim Pharmaceuticals, Inc(SIGNIFICANT), Merck & Co., Inc.(SIGNIFICANT), Cytokinetics(MODEST), Abbott Laboratories(MODEST), Regeneron(SIGNIFICANT), Novo Nordisk Inc.(MODEST) OTHER FINANCIAL BENEFIT: Gilead Sciences(MODEST)

View Full Disclosure